None listed
Conditions
Brief summary
The study aims to investigate the effects of short term supplementation with either palm-tocotrienol or palm-carotene on blood vessel function and cardiovascular disease risk in participants at risk of impaired vascular function. We hypothesise that supplementation with both palm-tocotrienol and palm-carotene will improve blood vessel function and cardiovascular disease risk factors compared to a control supplement.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
*Male or female *Type 2 diabetes (previously diagnosed and taking anti-diabetic medication or HbA1c of 7.0-10.0%) or impaired fasting glucose (fasting plasma glucose of 5.6 mmol/L and greater) or abdominal obesity identified by elevated waist circumference: equal of greater than 102 cm (men); equal or greater than 88 cm (women). *18-70 years * BMI: 20-45 kg/m2 * No abnormality of clinical significance on medical history * No history of coronary artery disease or cardiac (heart) abnormalities
Exclusion criteria
* Type 1 diabetes * Smoking * Known proteinuria or current malignancy * Known kidney, respiratory, gastrointestinal, cardiovascular or peripheral vascular disease * Known abnormal liver function tests * Known endocrinopathy unless participants are stable on treatment (have been using thyroxine for at least 3 months prior to study commencement (no changes in type and dose) and have no intention to change during study). * Pregnancy or lactating * Participated in regular vigorous physical exercise greater than 1 hour per week or greater than 2x, 30 minute sessions / week during the 3 months prior to the study * Have taken tocotrienol or carotene supplements during the 3 months prior to study * Taking supplements known to affect outcome measures (i.e. fish oil, vitamin C) unless supplements are ceased before trial commencement (3 months for fish oil, 2 weeks for vitamin C) or participants are stable on the supplements for at least 3 months prior to study commencement (no changes in type and dose) and have no intention to change during study. * Use of nitrate medication, non-steroidal anti-inflammatory medication (excluding aspirin) * Taking oral contraceptives or hormone replacement therapy during the 3 months prior to study * History of heavy alcohol consumption (> 5 STD drinks/day) * Volunteer unable to limit alcohol consumption for study duration * Currently on a weight reducing diet or have an eating disorder * Unwilling to be randomized to either experimental group * Extended absences due to travel or other commitments * Unable to comprehend or cope with study requirements